Fasting Insulin as an Independent Predictor of Metabolic Dysfunction-Associated Steatohepatitis (MASH) Severity

被引：0
|
作者：
Harrison, Stephen A.
Dubourg, Julie
Jeannin, Sophie
Colca, Jerry R.
Ratziu, Vlad
机构：
来源：
DIABETES | 2024年 / 73卷
关键词：
D O I：
10.2337/db24-1582-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1582-P
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Therapeutic landscape of metabolic dysfunction-associated steatohepatitis (MASH)
    Do, Albert
    Zahrawi, Frhaan
    Mehal, Wajahat Z.
    NATURE REVIEWS DRUG DISCOVERY, 2025, 24 (03) : 171 - 189
  • [2] Therapeutic landscape of metabolic dysfunction-associated steatohepatitis (MASH)
    Do, Albert
    Zahrawi, Frhaan
    Mehal, Wajahat Z.
    NATURE REVIEWS DRUG DISCOVERY, 2024,
  • [3] Therapeutic landscape of metabolic dysfunction-associated steatohepatitis (MASH)
    Albert Do
    Frhaan Zahrawi
    Wajahat Z. Mehal
    Nature Reviews Drug Discovery, 2025, 24 (3) : 171 - 189
  • [4] Insulin resistance as an independent predictor of metabolic dysfunction-associated steatohepatitis (MASH) severity: combined data from multiple therapeutic trials including more than 10, 000 patients
    Ratziu, Vlad
    Schattenberg, Jorn M.
    Alkhouri, Naim
    Noureddin, Mazen
    Charlton, Michael
    Dubourg, Julie
    Harrison, Stephen A.
    JOURNAL OF HEPATOLOGY, 2024, 80 : S464 - S464
  • [5] Silent MASH: A Case of Metabolic Dysfunction-Associated Steatohepatitis (MASH) with Normal Aminotransferases
    Li, Elizabeth
    Vallabhaneni, Manasa
    Lin, Joanne
    Hogan, Carolyn
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S2778 - S2778
  • [6] IMPACT OF FIBROSIS SEVERITY ON CLINICAL AND METAGENOMIC PROFILES IN MASH (METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS) PATIENTS
    Joung, Hyunchae
    Joo, Jaeryang
    Kim, KyungHwan
    Shin, Chang Hun
    Lee, Hye Won
    HEPATOLOGY, 2024, 80 : S788 - S789
  • [7] Metabolic dysfunction-associated steatohepatitis (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) require urgent attention by primary care physicians and endocrinologists
    Mauricio, Didac
    Escalada, Javier
    Perez, Antonio
    Romero-Gomez, Manuel
    Cusi, Kenneth
    Younoussi, Zobair M.
    Lazarus, Jeffrey V.
    ENDOCRINOLOGIA DIABETES Y NUTRICION, 2024, 71 (04): : 149 - 151
  • [8] Found in translation-Fibrosis in metabolic dysfunction-associated steatohepatitis (MASH)
    Wang, Shuang
    Friedman, Scott L.
    SCIENCE TRANSLATIONAL MEDICINE, 2023, 15 (716)
  • [9] Evaluating the Impact of Cenicriviroc in Metabolic Dysfunction-Associated Steatohepatitis (MASH): A Systematic Review
    Singh, Avneet
    Garcia, Alexander
    Hasan, Fariha
    Laique, Fatima
    Mohiuddin, Mubashir
    Haris, Muhammad
    Abidi, Zehara
    Jover, Queenzy
    Awadallah, Mina
    Wakil, Ali
    Nguyen, Tommy
    Roy, Satyajeet
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S1249 - S1250
  • [10] RECOMMENDATIONS FOR METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS ( MASH) DISEASE MANAGEMENT: A MODIFIED DELPHI PANEL
    Watzker, Anna
    Delegge, Mark
    Fernandes, Gail
    Melaragno, Matthew
    Williams, Rhys
    Godinho, Fatima
    Drymaliti, Kyriaki
    Engel, Samuel
    HEPATOLOGY, 2024, 80
12345